-
TYRA Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Tyra Biosciences (TYRA)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 104.89 mm | 104.89 mm | 104.89 mm | 104.89 mm | 104.89 mm | 104.89 mm |
Cash burn (monthly) | (no burn) | 9.31 mm | 9.53 mm | 8.34 mm | 5.97 mm | 5.31 mm |
Cash used (since last report) | n/a | 47.33 mm | 48.45 mm | 42.39 mm | 30.32 mm | 26.98 mm |
Cash remaining | n/a | 57.57 mm | 56.44 mm | 62.51 mm | 74.58 mm | 77.91 mm |
Runway (months of cash) | n/a | 6.2 | 5.9 | 7.5 | 12.5 | 14.7 |
13F holders | Current |
---|---|
Total holders | 117 |
Opened positions | 36 |
Closed positions | 20 |
Increased positions | 34 |
Reduced positions | 27 |
13F shares | Current |
---|---|
Total value | 675.33 bn |
Total shares | 70.87 mm |
Total puts | 6.00 k |
Total calls | 3.80 k |
Total put/call ratio | 1.6 |
Largest owners | Shares | Value |
---|---|---|
Ra Capital Management | 10.64 mm | $147.86 bn |
Boxer Capital | 6.45 mm | $157.79 mm |
Canaan Partners XI | 4.18 mm | $58.10 bn |
Alta Partners NextGen Fund II Management | 4.08 mm | $81.24 mm |
Alta Partners Management | 4.08 mm | $56.72 bn |
Nextech Vi Oncology SCSP | 4.06 mm | $64.77 mm |
Nextech Invest | 4.06 mm | $56.38 bn |
Biotechnology Value Fund L P | 3.94 mm | $58.02 mm |
BVF | 3.94 mm | $54.82 bn |
Canaan XI | 3.73 mm | $54.89 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
5 Feb 25 | Nina S Kjellson | Common Stock | Sell | Dispose S | Yes | No | 13.7611 | 3,511 | 48.32 k | 443,885 |
5 Feb 25 | Nina S Kjellson | Common Stock | Sell | Dispose S | Yes | No | 13.7611 | 1,890 | 26.01 k | 3,700,705 |
29 Jan 25 | Gulfo Adele M. | Common Stock Common Stock | Grant | Acquire A | No | No | 14.65 | 37,200 | 544.98 k | 37,200 |
23 Jan 25 | Nina S Kjellson | Common Stock | Sell | Dispose S | Yes | No | 16.2624 | 4,825 | 78.47 k | 3,702,595 |
21 Jan 25 | Nina S Kjellson | Common Stock | Sell | Dispose S | Yes | No | 16.3626 | 3,993 | 65.34 k | 3,707,420 |
17 Jan 25 | Nina S Kjellson | Common Stock | Sell | Dispose S | Yes | No | 16.4001 | 461 | 7.56 k | 447,396 |
17 Jan 25 | Nina S Kjellson | Common Stock | Sell | Dispose S | Yes | No | 16.4001 | 12,808 | 210.05 k | 3,711,413 |
16 Jan 25 | Nina S Kjellson | Common Stock | Sell | Dispose S | Yes | No | 16.287 | 835 | 13.60 k | 447,857 |
16 Jan 25 | Nina S Kjellson | Common Stock | Sell | Dispose S | Yes | No | 16.287 | 6,944 | 113.10 k | 3,724,221 |